CRTC2 and Insulin resistance: On the other hand, a long-term Tac treatment (8 weeks) has recently been shown to inhibit CREB-regulated transcription coactivator 2 (CRTC2) signaling that impacts hepatic metabolic homeostasis ultimately causing insulin resistance (Ling et al. 2020).